Your Location: Home > News > Company News >

Seven CapitalBio Products Certified by Thai FDA

Release Time:2017-08-10Browse:

Seven CapitalBio products were recently certified by Thai FDA. This laid a good foundation for CapitalBio Technology’s entrance into the Thai market.
The seven CapitalBio Products are:
1.     CapitalBioLuxScan 10K Microarray Scanner
2.     CapitalBio Nine Deafness Gene Mutations Detection Kit (Microarray)
3.     CapitalBioRTisochip-A Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer
4.     CapitalBio Respiratory Pathogens Nucleic Acid Detection Kit (Isothermal Amplification on Disk Chip)
5.     CapitalBio Mycobacteria Real-time PCR Detection Kit
6.     CapitalBio Mycobacteria Identification Array Kit
7.     CapitalBio Thalassemia Gene Mutations Detection Kit (Microarray)
CapitalBio Technology is a leading provider of life science solutions. It provides products and services in the fields of clinical diagnostics, scientific research, HLA typing, animal disease control, food safety testing, identification of traditional Chinese herbs, molecular breeding, NIPT, and liquid biopsy. Its products have been exported to more than 30 countries and regions.Exploring the markets in emerging economies constitutes an important part of CapitalBio Technology’s strategy. Optimistic about the expansion of the molecular diagnostics market in Thailand, CapitalBio Technology will make more efforts to develop the Thai market. More CapitalBio products are pending to be certified.